JPH02153840A - Production of dental crystallized glass - Google Patents
Production of dental crystallized glassInfo
- Publication number
- JPH02153840A JPH02153840A JP63306429A JP30642988A JPH02153840A JP H02153840 A JPH02153840 A JP H02153840A JP 63306429 A JP63306429 A JP 63306429A JP 30642988 A JP30642988 A JP 30642988A JP H02153840 A JPH02153840 A JP H02153840A
- Authority
- JP
- Japan
- Prior art keywords
- glass
- crystals
- crystallized glass
- dental
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011521 glass Substances 0.000 title claims abstract description 64
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- 239000013078 crystal Substances 0.000 claims abstract description 44
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 11
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 10
- 235000011010 calcium phosphates Nutrition 0.000 claims abstract description 10
- 229910052791 calcium Inorganic materials 0.000 claims abstract 2
- 239000011575 calcium Substances 0.000 claims abstract 2
- 238000000034 method Methods 0.000 abstract description 17
- 239000000463 material Substances 0.000 abstract description 9
- 238000005266 casting Methods 0.000 abstract description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 abstract description 4
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 abstract description 4
- 238000002844 melting Methods 0.000 abstract description 3
- 230000008018 melting Effects 0.000 abstract description 3
- 229910001635 magnesium fluoride Inorganic materials 0.000 abstract description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract 1
- 229910052681 coesite Inorganic materials 0.000 abstract 1
- 229910052593 corundum Inorganic materials 0.000 abstract 1
- 229910052906 cristobalite Inorganic materials 0.000 abstract 1
- 238000000151 deposition Methods 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 229910052682 stishovite Inorganic materials 0.000 abstract 1
- 229910052905 tridymite Inorganic materials 0.000 abstract 1
- 229910001845 yogo sapphire Inorganic materials 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 238000005452 bending Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000006060 molten glass Substances 0.000 description 5
- 229910052586 apatite Inorganic materials 0.000 description 4
- 238000009750 centrifugal casting Methods 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 239000005548 dental material Substances 0.000 description 4
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 239000003086 colorant Substances 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229910052634 enstatite Inorganic materials 0.000 description 3
- BBCCCLINBSELLX-UHFFFAOYSA-N magnesium;dihydroxy(oxo)silane Chemical compound [Mg+2].O[Si](O)=O BBCCCLINBSELLX-UHFFFAOYSA-N 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 229910000510 noble metal Inorganic materials 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 229910000497 Amalgam Inorganic materials 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- BYFGZMCJNACEKR-UHFFFAOYSA-N aluminium(i) oxide Chemical compound [Al]O[Al] BYFGZMCJNACEKR-UHFFFAOYSA-N 0.000 description 2
- 235000019646 color tone Nutrition 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000156 glass melt Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- -1 silver metals Chemical class 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、つ食、外傷などによって欠損あるいは変形し
た歯質を充填、補綴するためあるいは審美改善するため
に用いられる歯科用結晶化ガラスに関するものである。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to dental crystallized glass used for filling or prosthetic tooth structure that has been lost or deformed due to decay, trauma, etc., or for improving aesthetics. It is something.
[従来の技術J
従来より欠損あるいは変形しな歯質を充填、補綴するの
に用いる歯科材料としては、合金、アマルガム、アクリ
ル系レジン、陶材またはこれらの材料を組み合わせたも
のが存在する。[Prior Art J] Dental materials conventionally used to fill and restore missing or deformed tooth structure include alloys, amalgams, acrylic resins, porcelains, and combinations of these materials.
歯科材料には口腔内で不活性でありながら生体親和性が
良く、咀しやく力に耐え、比較的単純な製作工程によっ
て寸法精度の高い形状を得る事が出来、かつまた天然歯
と同様の審美性を有することが要求されるが、これらの
条件を全て満足する材料は未だ存在しないのが現状であ
る。Dental materials are inert in the oral cavity, have good biocompatibility, can withstand masticatory forces, can be formed into shapes with high dimensional accuracy through a relatively simple manufacturing process, and are similar to natural teeth. Although aesthetic properties are required, there is currently no material that satisfies all of these conditions.
すなわち合金やアマルガムは、天然歯と外観が異なるた
め審美性が悪く、一方アクリル系ポリマーや陶材は審美
性に優れているが、強度的に弱いため咀しやく力に耐え
ない事が多い、またこれらの材料を組み合わせてなる複
合構造物、例えば金属焼付陶材は咀しやく力に耐え、審
美性も良好であるが、為害作用が生じる恐れがあり、且
つ製作するのに高度な技術が要求される。In other words, alloys and amalgams have poor aesthetics because their appearance differs from natural teeth, while acrylic polymers and porcelains have excellent aesthetics, but are weak in strength and often cannot withstand the forces of mastication. Composite structures made by combining these materials, such as metal-fired porcelain, can withstand chewing forces and have good aesthetics, but they may have harmful effects and require advanced technology to manufacture. required.
また近年、歯科治療の分野において、上記材料に代わる
歯科材料として結晶化ガラスが注目を浴びており、現在
までに各種の歯科用結晶化ガラスが提案されている。現
在提案されている歯科用結晶化ガラスは大きく2つの系
に分かれ、すなわち1つは特開昭5L199742号公
報に開示されているようなマイカ系結晶を析出させるも
の、またもう1つは特公昭63−10939号公報に開
示されているようなアパタイト結晶等のリン酸カルシウ
ム系結晶を析出させるものである。Further, in recent years, in the field of dental treatment, crystallized glass has attracted attention as a dental material to replace the above-mentioned materials, and various dental crystallized glasses have been proposed to date. Currently proposed dental crystallized glasses are broadly divided into two systems: one that precipitates mica-based crystals as disclosed in JP-A-5L199742; Calcium phosphate crystals such as apatite crystals as disclosed in Japanese Patent No. 63-10939 are precipitated.
[発明が解決しようとする問題点]
元肥したように2つの系に分かれる歯科用結晶化ガラス
は、総じて天然歯と同様の審美性を有し、且つ色々な形
状に成形することが可能であるが、各々一長一短がある
。すなわちマイカ系結晶を析出する結晶化ガラスは、脆
性が無く、点衝撃に対して抗することができ、且つ破壊
を伝播することがないが、相対的に生体親和性に乏しく
、また寸法精度が悪いという欠点があり、またリン酸カ
ルシウム系結晶を析出する結晶化ガラスは、歯肉組織等
との生体親和性に優れているが、強度が相対的に弱く、
特に傷に対する強度劣化が大きいという欠点がある。[Problems to be solved by the invention] Dental crystallized glass, which can be divided into two systems, generally has the same aesthetic properties as natural teeth and can be molded into various shapes. However, each has its advantages and disadvantages. In other words, crystallized glass that precipitates mica-based crystals is not brittle, can withstand point impact, and does not propagate fracture, but it has relatively poor biocompatibility and poor dimensional accuracy. In addition, crystallized glass, which precipitates calcium phosphate crystals, has excellent biocompatibility with gingival tissues, etc., but its strength is relatively weak.
In particular, there is a drawback that the strength deteriorates significantly due to scratches.
本発明の目的は、元肥した歯科材料に要求される特性を
全て満足し、特に従来の歯科用結晶化ガラスに備わって
いなかった優れた生体親和性と高い機械的強度を兼ね備
えた歯科用結晶化ガラスの製造方法を提供することであ
る。The purpose of the present invention is to create a dental crystallized material that satisfies all the characteristics required of a source-fertilized dental material, and in particular has excellent biocompatibility and high mechanical strength, which were not possessed by conventional dental crystallized glass. An object of the present invention is to provide a method for manufacturing glass.
E問題点を解決するための手段]
本発明者等は種々の研究を重ねた結果、各ガラス原料の
混合割合を厳密に規制し、それを溶融し、成形し、熱処
理することによってガラス中に所望の量の四珪化フルオ
ロマイカ系結晶とリン酸カルシウム系結晶を析出させて
優れた生体親和性と高い機械的強度を有する結晶化ガラ
スを製造することができることを見い出した。Means for Solving Problem E] As a result of various studies, the present inventors have strictly regulated the mixing ratio of each glass raw material, melted it, formed it, and heat-treated it to form a glass material. It has been discovered that it is possible to produce crystallized glass having excellent biocompatibility and high mechanical strength by precipitating desired amounts of fluoromica tetrasilicide crystals and calcium phosphate crystals.
すなわち本発明の歯科用結晶化ガラスの製造方法は、重
量百分率でSiO□ 40.0〜70.0%、JO3゜
0〜7.8%、MgF28.0〜17.0%、Al2O
,0〜2.0%、に20 4.0〜20.0%、zro
□+ Ti0z 0.1〜15.0%、Ca0 0.1
”20.0%、p2o、o、t 〜20.0%の範囲に
あるガラス原料を溶融し、成形し、熱処理することによ
って四珪化フルオロマイカ系結晶とリン酸カルシウム系
結晶を析出させてなることを特徴とする。That is, the method for producing dental crystallized glass of the present invention includes SiO□ 40.0-70.0%, JO3゜0-7.8%, MgF 28.0-17.0%, Al2O
, 0-2.0%, 20 4.0-20.0%, zro
□+ Ti0z 0.1-15.0%, Ca0 0.1
``Fluoromica tetrasilicide crystals and calcium phosphate crystals are precipitated by melting glass raw materials in the range of 20.0%, p2o, o, t ~ 20.0%, molding, and heat treatment. Features.
本発明の歯科用結晶化ガラスの製造方法においてガラス
原料の量を上記のように限定したのは以下の理由による
。The reason why the amount of glass raw materials is limited as described above in the method for producing dental crystallized glass of the present invention is as follows.
5i02は、四珪化フルオロマイカ系結晶<KMg2.
5Si40+oFz)の構成成分であると共にガラスマ
トリックス相の強度を向上する成分であるが、40.0
%より少ない場合はガラスを結晶化熱処理する際にガラ
スが軟化変形しやすくなり、70.0%より多い場合ガ
ラスの溶融が困難になり、均一なガラスが得難くなる。5i02 is a tetrasilicated fluoromica crystal <KMg2.
5Si40+oFz) and is a component that improves the strength of the glass matrix phase.
If it is less than 70.0%, the glass will be easily softened and deformed when it is heat-treated for crystallization, and if it is more than 70.0%, it will be difficult to melt the glass and it will be difficult to obtain a uniform glass.
MgOは、四珪化フルオロマイカ系結晶の構成成分であ
るが、3.0%より少ない場合は四珪化フルオロマイカ
系結晶の析出量が極端に少なくなるため傷に対する強度
劣化が大きくなり、7.8%より多い場合はガラスを結
晶化熱処理する際にエンスタタイト結晶(MgOS i
03 )等の様な異種結晶が析出してガラスが白濁して
審美性が悪くなる。MgO is a constituent component of fluoromica tetrasilicide crystals, but if it is less than 3.0%, the amount of fluoromica tetrasilicide crystals precipitated will be extremely small, resulting in significant deterioration in strength against scratches. %, enstatite crystals (MgOS i
03) etc. are precipitated, the glass becomes cloudy and the aesthetics deteriorate.
MgF2は、四珪化フルオロマイカ系結晶の構成成分で
あるが、8.0%より少ない場合は四珪化フルオロマイ
カ系結晶の析出量が極端に少なくなって傷に対する強度
劣化が大きくなり、17.0%より多い場合はガラスを
結晶化熱処理する際にガラスが軟化変形しやすくなる。MgF2 is a constituent component of fluoromica tetrasilicide crystals, but if it is less than 8.0%, the amount of fluoromica tetrasilicide crystals precipitated will be extremely small, resulting in a large deterioration in strength against scratches. %, the glass tends to be softened and deformed during the crystallization heat treatment.
A1□03は、リン酸カルシウム系結晶を安定化させて
化学耐久性を良好にする成分であるが、2.0%より多
い場合はガラスを結晶化熱処理する際に異種結晶である
アイオライド結晶(Mg2AI4SiqO+s)が析出
しやすくなり好ましくない。すなわちアイオライド結晶
が析出するとガラスが白濁して審美性が悪くなると共に
硬度が高くなりすぎるという問題が生じる。A1□03 is a component that stabilizes calcium phosphate crystals and improves their chemical durability, but if the amount exceeds 2.0%, iolide crystals (Mg2AI4SiqO+s), which are foreign crystals, may be produced when glass is heat-treated for crystallization. is undesirable because it tends to precipitate. That is, when iolide crystals precipitate, the glass becomes cloudy, resulting in poor aesthetics and an excessively high hardness.
K2Oは、四珪化フルオロマイカ系結晶の構成成分であ
るが、4.0%より少ない場合はエンスタタイト結晶等
の異種結晶が析出するためにガラスが白濁して審美性が
悪くなり、20.0%より多い場合はガラスを結晶化熱
処理する際にマイカ系の粗大結晶が析出して均一なガラ
スが得難くなる。K2O is a component of tetrasilicated fluoromica crystals, but if it is less than 4.0%, foreign crystals such as enstatite crystals will precipitate, resulting in cloudy glass and poor aesthetics. %, coarse mica-based crystals will precipitate during the crystallization heat treatment of the glass, making it difficult to obtain a uniform glass.
ZrO2及びTiO2は、四珪化フルオロマイカ系結晶
の大きさを制御する成分であるが、0.1%より少ない
場合はこの効果が得られず、15.0%より多い場合は
エンスタタイト結晶等の異種結晶が析出するためガラス
が白濁して審美性が悪くなる。ZrO2 and TiO2 are components that control the size of tetrasilicated fluoromica crystals, but if it is less than 0.1%, this effect cannot be obtained, and if it is more than 15.0%, enstatite crystals etc. Due to the precipitation of foreign crystals, the glass becomes cloudy and the aesthetics deteriorate.
CaO及びP2O5は、リン酸カルシウム系結晶の構成
成分で生体親和性を良好にするために含有する成分であ
り、その含有量は各々 0.1〜20.0%である。e
aO及びP2O5が各々 0.1%より少ない場合は、
アパタイト結晶(Catn(PO,5)60)やトライ
カルシウムホスフェート結晶(3CaOP205)等の
リン酸カルシウム系結晶の析出がほとんどなく生体親和
性に乏しくなり、各々20.0%より多い場合はガラス
が失透しやすく均一なガラスが得難くなり、且つ大きな
粒径のアパタイト結晶が析出して審美性が悪くなる。CaO and P2O5 are constituent components of calcium phosphate crystals and are included to improve biocompatibility, and their content is 0.1 to 20.0% each. e
If aO and P2O5 are each less than 0.1%,
There is almost no precipitation of calcium phosphate crystals such as apatite crystals (Catn(PO,5)60) and tricalcium phosphate crystals (3CaOP205), resulting in poor biocompatibility, and if each exceeds 20.0%, the glass may devitrify. It becomes difficult to obtain a uniform glass, and apatite crystals with large grain sizes precipitate, resulting in poor aesthetics.
本発明の方法によって製造される歯科用結晶化ガラスは
、半透明の乳白色の色調を呈しており、天然歯の外観と
近似しているが、天然歯の色調は各人によって微妙に異
なっているためガラスを着色させることによってより天
然歯に近似させることができる。この着色方法には2通
りあり、すなわち1つはガラス原料に着色剤としてCe
O□、MnO□、センイ金属酸化物、貴金属酸化物、貴
金属ハロゲン化物、貴金属塩等の成分を添加する方法で
あり、もう1つは結晶化ガラスを成形した後、上薬を塗
布する方法である。 尚、着色剤の添加量はガラス10
0%に対して0.01〜8%であることが好ましい。す
なわち0.01%より少ない場合は着色剤としての効果
が得られず、また8%より多い場合は着色が濃くなりす
ぎるため好ましくない。The dental crystallized glass produced by the method of the present invention has a translucent milky white color, which approximates the appearance of natural teeth, but the color tone of natural teeth differs slightly from person to person. Therefore, by coloring the glass, it can be made to more closely resemble natural teeth. There are two methods for this coloring; one is to add Ce as a coloring agent to the glass raw material;
One method is to add components such as O□, MnO□, silver metal oxides, noble metal oxides, noble metal halides, and noble metal salts.The other method is to form crystallized glass and then apply an overcoat. be. In addition, the amount of colorant added is 10
It is preferable that it is 0.01 to 8% with respect to 0%. That is, if it is less than 0.01%, no effect as a coloring agent can be obtained, and if it is more than 8%, the coloring becomes too dark, which is not preferable.
さらに本発明では、先記した成分以外にも四珪化フロオ
ロマイ力結晶と適合する他の成分及びリン酸カルシウム
結晶と適合する他の成分、具体的には周期律表第■族、
第■族の金属酸化物およびセンイ金属の酸化物を添加す
ることが可能である。Furthermore, in the present invention, in addition to the above-mentioned components, other components compatible with tetrasilicified fluoromylic crystals and other components compatible with calcium phosphate crystals, specifically, Group Ⅰ of the periodic table,
It is possible to add metal oxides of group (I) and oxides of silver metals.
しかしながら本発明では、Na2Oを含有するとガラス
が分相して均一なガラスが得難くなると共に四珪化フル
オロマイカ系結晶の粒径が大きくなって審美性が悪くな
るため好ましくない。However, in the present invention, the inclusion of Na2O is not preferred because it causes phase separation of the glass, making it difficult to obtain a uniform glass, and also increases the grain size of the fluoromica tetrasilicide crystals, resulting in poor aesthetics.
以下に本発明の歯科用結晶化ガラスの製造方法を具体的
に示す。The method for producing the dental crystallized glass of the present invention will be specifically described below.
先記した量のガラス原料を1350〜1550℃で2〜
8時間溶融した後、鋳型内に注入して成形し、次いでこ
の成形体を鋳型から取り出して950〜1150℃で約
2〜8時間熱処理する。鋳造方法としては、遠心鋳造法
や真空鋳造法等が用いられる。すなわち遠心鋳造法とは
バネ式又はモーター式遠心鋳造機に鋳型をセットし、溶
融ガラスを適当量鋳型に注ぎ、直ちに遠心回転をスター
トして鋳型内にガラスを鋳造する方法である。また真空
鋳造法とは、カーボン又は白金ルツボ中にガラスを入れ
、その周囲にセットされた加熱器によってガラスを溶融
した後、鋳造機にセットした鋳型に溶融ガラスを注ぎ、
鋳造機内の空気ポンプで減圧し、減圧が完了した時点で
ルツボを反転して鋳型内にガラスを鋳造する方法である
。The amount of glass raw materials mentioned above was heated at 1350 to 1550°C for 2 to 30 minutes.
After being melted for 8 hours, it is poured into a mold and molded, and then this molded body is taken out from the mold and heat treated at 950 to 1150°C for about 2 to 8 hours. As the casting method, a centrifugal casting method, a vacuum casting method, etc. are used. That is, the centrifugal casting method is a method in which a mold is set in a spring-type or motor-type centrifugal casting machine, an appropriate amount of molten glass is poured into the mold, and centrifugal rotation is immediately started to cast glass in the mold. The vacuum casting method involves placing glass in a carbon or platinum crucible, melting the glass with a heater set around it, and then pouring the molten glass into a mold set in a casting machine.
In this method, the pressure is reduced using an air pump inside the casting machine, and once the pressure reduction is complete, the crucible is turned over and the glass is cast into the mold.
[実施例] 以下本発明を実施例に基づいて説明する。[Example] The present invention will be explained below based on examples.
次表は本発明の歯科用結晶化ガラスの実施FA(試料N
[L 1〜6 )及び比較例(試料N[L7.8)を示
すものである。The following table shows implementation FA (sample N) of the dental crystallized glass of the present invention.
[L 1-6 ) and a comparative example (sample N [L7.8)].
表 (型開%) 表の各ガラス試料は、次のように調製した。table (Mold opening%) Each glass sample in the table was prepared as follows.
表に示す割合で各ガラス原料を白金るつぼに入れ、電気
炉中で約1450℃で約4時間溶融した0次にこの溶融
ガラスをブロック状に成形し、約1050〜1075℃
で約4時間熱処理を行い結晶化ガラスを作製しな。粉末
X線法によって各試料の結晶相を観察したところ試料t
Ja 1〜6の結晶化ガラスには四珪化フルオロマイカ
結晶とアパタイト結晶が共に析出し、試料N[L7の結
晶化ガラスには四珪化フルオロマイカ結晶のみが析出し
、また試料N[L8のして8φX 1 m+sのプレー
ト及び3 X 4 X 36+u+の角柱を作製した6
表の生体親和性は元肥プレート状に加工した結晶化ガラ
スを用い、その平滑面及び粗造面に健康人の皮膚線維芽
細胞を48時間、37℃の条件で培養し、その細胞増殖
の程度によって、優、良の二段階で評価して表に示した
。また曲げ強度は、元肥角柱に加工した結晶化ガラスを
#600の研摩紙によって傷を付けた後、周知の三点荷
重試験法によってスパン30++us、クロスヘツドス
ピード0.51111/分で測定したものである。Each glass raw material was put into a platinum crucible in the proportion shown in the table and melted at about 1450°C for about 4 hours in an electric furnace.Then, this molten glass was formed into a block shape and heated to about 1050-1075°C.
Heat treatment was performed for about 4 hours to produce crystallized glass. When the crystal phase of each sample was observed using powder X-ray method, sample t
In the crystallized glasses of Ja 1 to 6, both fluoromica tetrasilicide crystals and apatite crystals were precipitated, and in the crystallized glasses of sample N[L7, only fluoromica tetrasilicide crystals were precipitated, and in the crystallized glass of sample N[L8]. A plate of 8φ×1 m+s and a prism of 3×4×36+u+ were made6.
The biocompatibility shown in the table is determined by culturing skin fibroblasts from healthy individuals on the smooth and rough surfaces of crystallized glass processed into a starter plate at 37°C for 48 hours. The results are rated in two grades, excellent and good, and are shown in the table. The bending strength was measured using the well-known three-point load test method at a span of 30++us and a crosshead speed of 0.51111/min after scratching crystallized glass processed into a square cylinder with #600 abrasive paper. be.
本発明品(試料N[L1〜6)と従来品(試料陽7及び
8)の生体親和性及び曲げ強度を比べると本発明品が生
体親和性に優れ、且つ高い曲げ強度を有しているのに対
して、従来品である試料NIL7は曲げ強度は本発明品
と同程度であるが、生体親和性が本発明品に比べてやや
劣っており、また試料陽8は生体親和性に優れているが
曲げ強度が極端に低い。Comparing the biocompatibility and bending strength of the products of the present invention (Samples N [L1 to 6) and conventional products (Samples No. 7 and 8), the products of the present invention have excellent biocompatibility and high bending strength. On the other hand, sample NIL7, which is a conventional product, has the same bending strength as the product of the present invention, but its biocompatibility is slightly inferior to that of the product of the present invention, and sample Y8 has excellent biocompatibility. However, its bending strength is extremely low.
また元肥各溶融ガラスを次のように鋳造した。In addition, each of the original molten glasses was cast as follows.
まず用意した原型に溶融したパラフィンを流し込み、パ
ラフィンを硬化させ、ワックス模型を作製し、該ワック
ス模型にガラスを導くためのパラフィンのスプール線を
溶着した後、エチルシリケート系埋没材に埋没した。埋
没材が硬化した後、徐々に120〜150℃まで昇温し
でワックス模型及びスプール線を焼却し、次いで徐々に
昇温しで700〜800℃で継留することによって鋳型
を作製した。First, molten paraffin was poured into a prepared model, the paraffin was hardened, a wax model was created, a paraffin spool wire for guiding glass was welded to the wax model, and the model was embedded in an ethylsilicate investment material. After the investment material had hardened, the wax model and spool wire were incinerated by gradually increasing the temperature to 120-150°C, and then the mold was produced by gradually increasing the temperature and retaining at 700-800°C.
一方、溶融ガラスを小さなブロックに成形し、それを1
300〜1500℃に再溶融したガラス融液を該鋳型の
上面に注ぎ、遠心鋳造機を用いて完成した。On the other hand, mold the molten glass into small blocks and
A glass melt remelted at 300 to 1500°C was poured onto the upper surface of the mold, and the mold was completed using a centrifugal casting machine.
こうして作製したガラス体を鋳型からはずして約100
0〜1100℃で約4時間熱処理した。各試料を目視に
よって観察したところいずれも天然歯と同等の良好な半
透明性を有しており、特に着色剤を含有させたNo、
3とN[L 6の試料が天然歯に近い色調を呈し審美性
に優れていた。The glass body produced in this way was removed from the mold and
Heat treatment was performed at 0 to 1100°C for about 4 hours. Visual observation of each sample revealed that all of them had good translucency equivalent to natural teeth, and in particular, No.
Samples No. 3 and N[L 6 exhibited color tones close to natural teeth and were excellent in aesthetics.
[発明の効果]
以上のように本発明方法によって製造された歯科用結晶
化ガラスは、審美性に優れ、特に優れた生体親和性と高
い機械的強度を兼ね備え、さらに鋳造法によって製造す
ることが可能であるため寸法精度の高い人工歯を得るの
に適している。また本発明における歯科用結晶化ガラス
は歯学教育過程における切削実習用や供覧用としても用
いることができるのは言うまでもない。[Effects of the Invention] As described above, the dental crystallized glass produced by the method of the present invention has excellent aesthetics, particularly excellent biocompatibility, and high mechanical strength, and furthermore, it can be produced by a casting method. This makes it suitable for obtaining artificial teeth with high dimensional accuracy. It goes without saying that the dental crystallized glass of the present invention can also be used for cutting practice and viewing in the dental education process.
特許出願人 日本電気硝子株式会社 代表者 岸 1)清 作Patent applicant: Nippon Electric Glass Co., Ltd. Representative Kishi 1) Kiyoshi Saku
Claims (1)
3.0〜7.8%、MgF_28.0〜17.0%、A
l_2O_30〜2.0%、K_2O4.0〜20.0
%、ZrO_2+TiO_20.1〜15.0%、Ca
O0.1〜20.0%、P_2O_50.1〜20.0
%の範囲にあるガラス原料を溶融し、成形し、熱処理す
ることによつて四珪化フルオロマイカ系結晶とリン酸カ
ルシウム系結晶を析出させてなることを特徴とする歯科
用結晶化ガラスの製造方法。SiO_240.0-70.0% by weight percentage, MgO
3.0-7.8%, MgF_28.0-17.0%, A
l_2O_30-2.0%, K_2O4.0-20.0
%, ZrO_2+TiO_20.1-15.0%, Ca
O0.1-20.0%, P_2O_50.1-20.0
1. A method for producing dental crystallized glass, characterized in that glass raw materials in a range of 1.5% are melted, shaped, and heat treated to precipitate fluoromica tetrasilicide crystals and calcium phosphate crystals.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63306429A JPH02153840A (en) | 1988-12-02 | 1988-12-02 | Production of dental crystallized glass |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63306429A JPH02153840A (en) | 1988-12-02 | 1988-12-02 | Production of dental crystallized glass |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02153840A true JPH02153840A (en) | 1990-06-13 |
Family
ID=17956911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63306429A Pending JPH02153840A (en) | 1988-12-02 | 1988-12-02 | Production of dental crystallized glass |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02153840A (en) |
-
1988
- 1988-12-02 JP JP63306429A patent/JPH02153840A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4744759A (en) | Inserts for composite dental restorations | |
US5057018A (en) | Microcrystalline inserts for megafilled composite dental restorations | |
CN110139840B (en) | Lithium silicate glass ceramic | |
JPH02149447A (en) | Dental crystallized glass | |
JP3113230B2 (en) | Chemically stable translucent apatite glass ceramic | |
CN110590163A (en) | Dental block for cutting and method for manufacturing same | |
CN114671607A (en) | Does not contain Al2O3Lithium silicate glass composition of | |
Höland et al. | Bioceramics and their application for dental restoration | |
CN109592904B (en) | High strength lithium silicate glass composition with high shielding property | |
JP3254068B2 (en) | Crystallized glass for pearl nucleus material and its manufacturing method | |
JPS6270244A (en) | Dental crown material | |
JPS62123042A (en) | Crystallized glass for dental material having improved aesthetic property and production thereof | |
JPS63176335A (en) | Crystallized glass and production thereof | |
JPH0714826B2 (en) | Glass-ceramic crown and method of manufacturing the same | |
JPH02153840A (en) | Production of dental crystallized glass | |
JPH1036136A (en) | Ceramic for dentistry | |
JPH0193439A (en) | Production of crystallized glass for dental material and embedding material | |
JPH02153839A (en) | Dental crystallized glass | |
JPH02153841A (en) | Production of dental crystallized glass | |
JP3152983B2 (en) | Crystallized glass for restoration of tooth or tooth defects and its manufacturing method | |
JP4421155B2 (en) | Dental glass | |
JPH059104A (en) | Crystallized glass for dental use | |
TWI838766B (en) | Dental block and method for producing the same | |
RU2144814C1 (en) | Glassceramic material for manufacturing dentures | |
JPH059040A (en) | Crystallized glass for dental use |